Retour sur lavenir.net
   UCB 253.800 € (-0,24 %)     ARGENX SE 812.200 € (-0,10 %)     AEDIFICA 70.100 € (+1,30 %)     CMB.TECH 13.300 € (-1,48 %)     KBC 121.000 € (-0,08 %)     DEME GROUP 172.800 € (-0,80 %)     UMICORE 20.360 € (-4,23 %)     OXURION 0.003 € (0,00 %)     JENSEN-GROUP 84.200 € (+0,24 %)     ONWARD MEDICAL 2.530 € (-2,50 %)     VASTNED 29.650 € (+1,89 %)     CAMPINE 210.000 € (-5,41 %)     CARE PROPERTY INV. 12.700 € (+1,44 %)     RETAIL ESTATES 69.600 € (+1,61 %)     KBC ANCORA 83.600 € (-0,24 %)     SOFINA 228.200 € (-0,95 %)     SYENSQO 66.500 € (+1,76 %)     DECEUNINCK 2.265 € (+0,89 %)     ACKERMANS V.HAAREN 274.000 € (-1,86 %)     GBL 78.450 € (-0,38 %)     AB INBEV 70.580 € (+1,61 %)     EKOPAK 3.440 € (-1,57 %)     XIOR 27.250 € (+0,55 %)     IBA 16.920 € (-1,05 %)     ASCENCIO 51.800 € (+0,58 %)     SIPEF 90.200 € (0,00 %)     HOME INVEST BE. 19.360 € (+1,15 %)     LOTUS BAKERIES 11 400.000 € (+0,35 %)     PROXIMUS 5.830 € (+1,13 %)     CELYAD ONCOLOGY 0.228 € (0,00 %)     TITAN S.A. 51.100 € (-1,73 %)     MELEXIS 72.700 € (-8,44 %)     GIMV 45.400 € (-1,20 %)     ONTEX GROUP 2.380 € (0,00 %)     CENERGY 23.080 € (-3,03 %)     AGFA-GEVAERT 0.420 € (+0,96 %)     EVS 27.000 € (-0,92 %)     MATERIALISE 6.500 € (+3,17 %)     BREDERODE 103.600 € (-0,38 %)     VIOHALCO 19.000 € (-1,45 %)     BEKAERT 39.650 € (-1,86 %)     NYXOAH 1.452 € (-8,22 %)     AGEAS 70.650 € (-0,07 %)     TUBIZE-FIN 216.400 € (-1,01 %)     SHURGARD 26.850 € (+2,68 %)     CIE BOIS SAUVAGE 307.000 € (0,00 %)     VAN DE VELDE 30.000 € (0,00 %)     KINEPOLIS GROUP 36.150 € (+0,42 %)     ORANGE BELGIUM 21.500 € (0,00 %)     SOLVAY 26.220 € (+0,15 %)     RECTICEL 11.380 € (+3,64 %)     VGP 86.000 € (-0,92 %)     ELIA GROUP 137.600 € (-0,29 %)     MONTEA 67.500 € (+0,45 %)     TESSENDERLO 20.250 € (+0,25 %)     BPOST 1.644 € (-0,96 %)     TINC 11.260 € (+0,18 %)     AZELIS GROUP 9.885 € (-1,10 %)     ENERGYVISION 14.860 € (+0,68 %)     WERELDHAVE BELGIUM 53.400 € (+1,14 %)  
   LAKEFRONT BIOTHER. 26.860 € (+1,74 %)     STMICROELECTRONICS 58.300 € (-7,99 %)     ASML HOLDING 1 509.800 € (-7,28 %)     PERNOD RICARD 65.880 € (+5,48 %)     AIRBUS 203.950 € (-2,60 %)     STELLANTIS NV 4.985 € (-0,84 %)     L'OREAL 388.350 € (+2,74 %)     EUTELSAT COMMUNIC. 2.466 € (-3,29 %)     BUREAU VERITAS 27.220 € (-0,22 %)     MAGNUM 16.400 € (+0,86 %)     AEGON 7.706 € (-0,26 %)     PHARMING GROUP 1.250 € (+1,58 %)     PROSUS 39.305 € (+3,01 %)     PROLOGUE 0.310 € (-8,55 %)     BE SEMICONDUCTOR 241.900 € (-6,28 %)     UBISOFT ENTERTAIN 6.016 € (+5,92 %)     SHELL PLC 35.275 € (+3,26 %)     ABN AMRO BANK N.V. 38.490 € (-0,36 %)     PHILIPS KON 24.660 € (+0,65 %)     AMG 32.540 € (-2,92 %)     EXOR NV 69.350 € (-0,50 %)     INFOTEL 40.350 € (-1,22 %)     ING GROEP N.V. 28.350 € (-1,29 %)     CEGEDIM 10.480 € (+0,77 %)     X-FAB 7.725 € (-10,90 %)     LHYFE 1.860 € (0,00 %)     DBV TECHNOLOGIES 2.874 € (+3,53 %)     SPINEWAY 0.125 € (-10,84 %)     NSI N.V. 17.420 € (+0,93 %)     CREDIT AGRICOLE 17.600 € (-1,40 %)     PLANISWARE 21.100 € (-2,31 %)     SANOFI 75.780 € (+1,70 %)     ESSILORLUXOTTICA 175.900 € (+1,91 %)     HAFFNER ENERGY 0.230 € (-8,18 %)     HERIGE 22.000 € (-0,45 %)     FORVIA 9.032 € (-2,10 %)     MERSEN 38.100 € (-6,80 %)     TOTALENERGIES 67.780 € (+0,94 %)     VALEO 12.895 € (-4,06 %)     DANONE 74.000 € (+2,07 %)     ATON 0.010 € (0,00 %)     ASM INTERNATIONAL 896.600 € (-7,03 %)     UNILEVER 55.040 € (+3,05 %)     SECHE ENVIRONNEM. 77.800 € (-1,39 %)     INVENTIVA 3.325 € (-2,64 %)     CSG 14.564 € (-2,01 %)     OVH 16.800 € (+0,96 %)     CIECHARGEURSINVEST 7.400 € (-1,33 %)     HAL TRUST 165.600 € (-0,36 %)     CARVOLIX 5.900 € (+34,09 %)     LVMH 495.800 € (+0,90 %)     AIR LIQUIDE 178.180 € (+0,33 %)     UNIBAIL-RODAMCO-WE 103.100 € (+0,54 %)     CROSSJECT 1.666 € (-4,25 %)     SIF HOLDING 4.185 € (-0,71 %)     ARCELORMITTAL SA 56.120 € (-1,47 %)     EURONEXT 149.600 € (+0,47 %)     RENAULT 26.330 € (+0,69 %)     SAFRAN 347.200 € (-2,77 %)     TKH GROUP 42.660 € (-2,78 %)  
News Réglementées
04/04/2023 12:47

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

04-Apr-2023 / 11:47 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

31 March 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,555,413

9.42%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,555,413

9.42%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

1,500

109.06 USD

US$0.0001 ordinary shares

Purchase

4,463

109.14 USD

US$0.0001 ordinary shares

Sale

715

109.14 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière